Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP212225V

CXCL14/BRAK Antibody (RM0206-17P3), DyLight 405, Novus Biologicals™
SDP

Catalog No. NBP212225V Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP212225V 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP212225V Supplier Novus Biologicals Supplier No. NBP212225V
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

CXCL14/BRAK Monoclonal specifically detects CXCL14/BRAK in Mouse samples. It is validated for Western Blot.

Specifications

Antigen CXCL14/BRAK
Applications Western Blot
Classification Monoclonal
Clone RM0206-17P3
Conjugate DyLight 405
Dilution Western Blot
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias BMAC, BRAKKEC, chemokine (C-X-C motif) ligand 14, Chemokine BRAK, member 14 (BRAK), MIP-2 gamma, MIP2G, MIP-2G, NJACKec, SCYB14MGC10687, Small-inducible cytokine B14
Gene Symbols CXCL14
Host Species Rat
Immunogen Mouse recombinant CXCL14/BRAK
Purification Method Protein A or G purified
Quantity 0.1 mL
Research Discipline Biologically Active Proteins
Primary or Secondary Primary
Gene ID (Entrez) 9547
Target Species Mouse
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.